TipRanks
Benitec Biopharma Ltd (BNTC)
NASDAQ:BNTC
US Market
BNTC
Benitec Biopharma
RESEARCH TOOLSreports
Want to see BNTC full AI Analyst Report?

Benitec Biopharma (BNTC) Income Statement

316 Followers

Benitec Biopharma Income Statement

Last quarter (Q4 2026), Benitec Biopharma's total revenue was AU$0.00, a decrease of -100.00% from the same quarter last year. In Q4, Benitec Biopharma's net income was AU$-12.81M. See Benitec Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 26Jun 25Jun 24Jun 23Jun 22
Total Revenue
$ 0.00$ 0.00$ 0.00$ 75.00K$ 73.00K
Gross Profit
$ -481.00K$ -396.00K$ -343.00K$ 75.00K$ 64.00K
Operating Expenses
$ 50.71M$ 41.37M$ 22.49M$ 19.16M$ 17.92M
Depreciation and Amortization
$ 481.00K$ 396.00K$ 343.00K$ 381.00K$ 392.00K
EBITDA
$ -50.71M$ -41.37M$ -22.15M$ -18.70M$ -17.78M
Operating Income
$ -51.19M$ -41.77M$ -22.49M$ -19.08M$ -17.85M
Other Income/Expenses
$ 5.65M$ 3.85M$ 739.00K$ -481.00K$ -354.00K
Pretax Income
$ -45.55M$ -37.92M$ -21.75M$ -19.56M$ -18.21M
Net Income
$ -45.55M$ -37.92M$ -21.75M$ -19.56M$ -18.21M
Per Share Metrics
Basic EPS
$ -0.98$ -1.05$ -2.68$ -14.12$ -19.31
Diluted EPS
$ -0.98$ -1.05$ -2.68$ -14.12$ -19.31
Weighted Average Shares Outstanding
 46.56M 36.21M 10.26M 1.39M 1.92M
Weighted Average Shares Outstanding (Diluted)
 46.56M 36.21M 10.28M 1.39M 1.92M

Benitec Biopharma Earnings and Revenue History